Taken together, these results suggest that IFI30‐mediated EGFR/AKT/GSK3β/β‐catenin signaling not only promotes the EMT‐like phenotype by up‐regulating the expression of Slug, but also subsequently enhanced invasion and chemoresistance of glioma cells (Figure 6I). Here, IFI30 is linked to central nervous system cancer.